Status:
UNKNOWN
Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon
Lead Sponsor:
Yaounde Central Hospital
Conditions:
Chronic Heart Failure (CHF)
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory patients with stable chronic heart failure \[New York Heart Association (NYHA) class II/III\]. Patients will be...
Detailed Description
CARECA-CHF study is a non-randomized, prospective, single-arm study, multicentric study. Patients with stable chronic heart failure \[New York Heart Association (NYHA) class II/III\] will be enrolled ...
Eligibility Criteria
Inclusion
- Patients with stable chronic heart failure confirmed by a cardiac ultrasound and whose severity is rated stage II or III of NYHA followed at Yaoundé central hospital and Yaoundé general hospital;
- Stable under treatment;
- Whose cardiac ultrasound is less than six months old;
- Having given his free and informed consent.
Exclusion
- Poor adherence to the cardiac rehabilitation program activities;
- Patients lost insight the program;
- Withdrawal of informed consent.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04790214
Start Date
March 1 2021
End Date
September 1 2021
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Chris Nadège Nganou-Gnindjio
Yaoundé, Cameroon, BP: 35307 Bastos